Intrinsic Medicine, Inc. Contracts & Agreements
30 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (1)
- Human Resources (7)
- Intellectual Property (7)
- Uncategorized (2)
- Form of Underwriting Agreement (Filed With SEC on May 4, 2022)
- Form of Common Stock Purchase Warrant (Representatives Warrant) (Filed With SEC on May 4, 2022)
- Intrinsic Medicine, Inc. 2022 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on May 4, 2022)
- Intrinsic Medicine, Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on May 4, 2022)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on April 26, 2022)
- Registration Rights Agreement, dated August 31, 2021, by and among the Registrant and the investors listed on Exhibit A thereto (Filed With SEC on April 8, 2022)
- Form of Common Stock Purchase Warrant (Bridge Warrant) (Filed With SEC on April 8, 2022)
- Common Stock Purchase Warrant (Placement Agent Warrant) (Filed With SEC on April 8, 2022)
- Form of 12% Senior Secured Convertible Promissory Note (Bridge Note) (Filed With SEC on April 8, 2022)
- Common Stock Purchase Warrant (SOSV Warrant) (Filed With SEC on April 8, 2022)
- Form of Indemnity Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on April 8, 2022)
- Intrinsic Medicine, Inc. 2021 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement, Notice of Exercise and Early Exercise Agreement, thereunder (Filed With SEC on April 8, 2022)
- Intrinsic Medicine, Inc. Non-Employee Director Compensation Policy (Filed With SEC on April 8, 2022)
- License and Supply Agreement, by and between Glycosyn, LLC and the Registrant, dated July 30, 2020 (Filed With SEC on April 8, 2022)
- Amendment No. 1 to License, Clinical Supply and Partnership Agreement, by and between Glycosyn, LLC and the Registrant, dated January 21, 2021 (Filed With SEC on April 8, 2022)
- Acknowledgement Letter regarding License, by and between Childrens Hospital Medical Center and Registrant, dated March 9, 2022 (Filed With SEC on April 8, 2022)
- License Agreement, by and between the Registrant and The Regents of the University of California, dated October 10, 2018 (Filed With SEC on April 8, 2022)
- Amendment No. 1 to License Agreement, by and between the Registrant and The Regents of the University of California, dated October 10, 2019 (Filed With SEC on April 8, 2022)
- Amendment No. 2 to License Agreement, by and between the Registrant and The Regents of the University of California, dated November 30, 2020 (Filed With SEC on April 8, 2022)
- Amendment No. 3 to License Agreement, by and between the Registrant and The Regents of the University of California, dated February 2, 2022 (Filed With SEC on April 8, 2022)
- Research and Development Collaboration Agreement, by and between the Registrant and Arpeggio Biosciences, Inc., dated December 22, 2020 (Filed With SEC on April 8, 2022)
- Amended and Restated Offer Letter, by and between the Registrant and Alexander Martinez to be effective immediately upon the closing of this offering (Filed With SEC on April 8, 2022)
- Amended and Restated Employment Agreement, by and between the Registrant and Jason Ferrone to be effective immediately upon the closing of this offering (Filed With SEC on April 8, 2022)
- Amended and Restated Employment Agreement, by and between the Registrant and Emil Chuang, M.B.B.S. FRACP to be effective immediately upon the closing of this offering (Filed With SEC on April 8, 2022)
- Amended and Restated Employment Agreement, by and between the Registrant and Dustin Crawford to be effective immediately upon the closing of this offering (Filed With SEC on April 8, 2022)
- Securities Purchase Agreement by and among the Registrant and the investors who are a signatory thereto, dated August 31, 2021 (Filed With SEC on April 8, 2022)
- Omnibus Amendment #1 to Financing Agreements by and between the Registrant and the investor who is a signatory thereto (Filed With SEC on April 8, 2022)
- Security Agreement by and among the Registrant and the investors who are a signatory thereto, dated August 31, 2021 (Filed With SEC on April 8, 2022)
- Retention Agreement, dated April 3, 2022, by and between the Registration and Jason Ferrone (Filed With SEC on April 8, 2022)
- Common Stock Issuance Agreement, dated April 5, 2022, by and between Registrant and SOSV IV, LLC (Filed With SEC on April 8, 2022)
